On this day, May 5, 1903, James Beard, US culinary expert, author (Delights & Prejudices), was born in Portland, Ore.
Also on this day, May 5, 1945, A Japanese balloon bomb exploded on Gearhart Mountain in Oregon, killing Mrs. Elsie Mitchell, the pregnant wife of a minister, and five children after they attempted to drag it out the woods in Lakeview, Oregon. The balloon was armed, and exploded soon after they began tampering with it. They became the 1st and only known American civilians to be killed in the continental US during World War II.
Also on this day, May 5, 1945, Bly minister Archie Mitchell, his pregnant wife Elsie, and five children from Mitchell's Sunday school class were on a Saturday morning picnic. Thirteen miles northeast of Bly, or about sixty miles northeast of Klamath Falls, Mitchell parked the car, and Elsie and the children headed to Leonard Creek. Mitchell later remembered: "As I got out of the car to bring the lunch, the others were not far away and called to me they had found something that looked like a balloon. I heard of Japanese balloons so I shouted a warning not to touch it. But just then there was a big explosion. I ran up there--and they were all dead." It was a Japanese balloon bomb. They were 70 feet tall with a 33-foot diameter paper canopy connected to the main device by shroud lines. Balloons inflated with hydrogen followed the jet stream at an altitude of 30,000 feet.
Oregon has a plan to prioritize minorities
The FDA’s advisory committee has voted to approve an emergency use authorization for the Pfizer-Biontech COVID-19 vaccine for kids, ages 16+ and adults. This gives the go ahead for the manufacturer to distribute the vaccine should the FDA as a whole agree which they have not ignored in the past. The CDC Advisory Committee on Immunization Practices or ACIP committee previously voted last week to prioritize healthcare workers, long term staff and residents to receive the vaccine.
Public testimony was heard, discussion on two topics were completed over the course of the long day from 9-6pm.
Discussions were short as commenters were allowed two minutes. Dr. Gruber from Pfizer gave a presentation on the efficacy and safety. The efficacy was touted as 95% and approval was based on two endpoints; participants having at least one symptom plus a central lab positive PCR test.
The data presented only included trial data analyzed up until November 14 and had glaring omissions. For example, there were ZERO black participants in the vaccine group and only three Hispanic. How is that sufficient data on a demographic that has reportedly been disproportionately affected by COVID-19? Will Governor Brown’s Vaccine Workgroup approve the vaccine in spite of these gaps as she has said she will prioritize solving COVID-19 inequities?
Oregon’s vaccination plan includes fighting for, “populations disproportionately impacted by COVID-19 and with historic disparities in vaccination rates, including seasonal influenza, will need specific interventions to ensure access to COVID-19 vaccine in culturally appropriate settings.
These populations include, but are not limited to:
- Black and African American communities
- Latino, Latina and Latinx populations
- Migrant and seasonal farm workers and other agricultural and food processing workers
Some side effects reported are appendicitis, Bell’s Palsy and severe anaphylaxis. 60 days of following trial participants seemed insufficient to many commenters and a few panel members. However, there was also concern that millions of people would not get the vaccine if there was a perception of harm as was
announced with two healthcare workers experiencing a severe reaction. Had they not had an epi pen they could have died. Dr. Paul Offit suggested a study to follow up with individuals who have peanut and egg allergies but was dismissed since egg protein is not an issue for this vaccine.
Aside from diversity issues, questions remain on the lack of long term data in minorities and all patients, whether the vaccine will cause an enhanced immune response in elderly patients and how long the vaccine works. There is a concern in pregnant women that due to DNA replication occurring during pregnancy, that the messenger RNA could alter chromosomes. The FDA published its findings including side effects that are so far known in a
recent report.
--Nicole DeGraff| Post Date: 2020-12-10 16:11:32 | Last Update: 2020-12-10 16:57:50 |
